MENU
+Compare
SMRI
ETF ticker: NASDAQ
AS OF
Sep 5, 12:17 PM (EDT)
Price
$34.17
Change
-$0.05 (-0.15%)
Net Assets
460.76M

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Large Value
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Sep 04, 2025

Momentum Indicator for SMRI turns positive, indicating new upward trend

SMRI saw its Momentum Indicator move above the 0 level on August 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned positive. In of the 24 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SMRI just turned positive on August 14, 2025. Looking at past instances where SMRI's MACD turned positive, the stock continued to rise in of 18 cases over the following month. The odds of a continued upward trend are .

SMRI moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SMRI crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in of 137 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMRI moved out of overbought territory on September 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMRI broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SMRI entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Exxon Mobil Corp (NYSE:XOM), Chevron Corp (NYSE:CVX), Merck & Co (NYSE:MRK), QUALCOMM (NASDAQ:QCOM), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), ConocoPhillips (NYSE:COP), Nike (NYSE:NKE), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 65.01B. The market cap for tickers in the group ranges from 5.68B to 479.19B. XOM holds the highest valuation in this group at 479.19B. The lowest valued company is MRP at 5.68B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was 7%. For the same ETF, the average monthly price growth was 26%, and the average quarterly price growth was 75%. TOL experienced the highest price growth at 5%, while ON experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was -23% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 42
Price Growth Rating: 43
SMR Rating: 54
Profit Risk Rating: 54
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Fundamentals
Details
Category
Large Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com